Therefore analyses of VEGF and bFGF expressions in haematological malignancies, including NHL, attracted the attention of many researchers [3, 20–22], while there have been fewer studies addressing the role of polymorphic features located within the genes coding for these two angiogenic factors [14, 23, 24] with only two reports describing the association of VEGF genetic polymorphisms with the clinical characteristics of NHL in Asian patients from China [23] and Korea [24]. Here, FGF2 is linked to non-Hodgkin lymphoma.